Trial intelligence / Profile preview

Randomized double-blind parallel-controlled trial of ACYW135 meningococcal conjugate vaccine in children 2 months to 6 years

CTR20130162Phase 3Completed

Sponsor
Beijing Minhai Biological
Start
Apr 2014
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of Meningococcal conjugate vaccine quadrivalent in meningococcal meningitis, meningitis, sponsored by Beijing Minhai Biological. Started Apr 2014; status: completed.

02

Drugs

Meningococcal conjugate vaccine quadrivalent
03

Conditions

meningococcal meningitismeningitis

Beyond the preview

Go deeper on CTR20130162.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130162.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call